Drug
Bbi608
Bbi608: highest development phase Phase 2, developed by Sumitomo Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| BBI608 NCT01776307 | Phase 2 | Colorectal Cancer |
| BBI608 NCT02347917 | Phase 1/2 | Malignant Pleural Mesothelioma |
Latest
No recent events.
Follow Bbi608 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.